Tag
AI drug discovery
2 articles
Industry News/Jun 7
Why Reid Hoffman leaving Microsoft’s board matters more than his titl…
Reid Hoffman’s exit from Microsoft’s board is a bet on focused founder control in AI drug discovery.
AI Agent/Jun 7
Reid Hoffman leaves Microsoft board for Manus AI
Reid Hoffman is leaving Microsoft’s board after nearly a decade to focus on Manus, his AI drug discovery startup with $50M+ raised.